BIM
GSK icon

BlackRock Investment Management’s GSK GSK Stock Holding History

BlackRock Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$17.2M Sell
356,374
-38,840
-10% -$1.92M 0.02% 766
2016
Q3 		$21.3M Sell
395,214
-10,180
-3% -$558K 0.03% 562
2016
Q2 		$22M Buy
405,394
+45,764
+13% +$2.41M 0.03% 534
2016
Q1 		$18.2M Buy
359,630
+76,214
+27% +$3.8M 0.02% 619
2015
Q4 		$14.3M Sell
283,416
-12,159
-4% -$620K 0.02% 732
2015
Q3 		$14.2M Sell
295,575
-158,721
-35% -$8.26M 0.02% 716
2015
Q2 		$23.7M Buy
454,296
+29,325
+7% +$1.65M 0.03% 513
2015
Q1 		$24.5M Buy
424,971
+91,616
+27% +$5.25M 0.03% 486
2014
Q4 		$17.8M Sell
333,355
-19,577
-6% -$1.1M 0.02% 605
2014
Q3 		$20.3M Sell
352,932
-195,936
-36% -$12M 0.03% 519
2014
Q2 		$36.7M Buy
548,868
+90,129
+20% +$6.1M 0.05% 348
2014
Q1 		$30.6M Buy
458,739
+53,864
+13% +$3.64M 0.04% 371
2013
Q4 		$27M Buy
404,875
+188,788
+87% +$12.2M 0.04% 403
2013
Q3 		$13.6M Sell
216,087
-34,016
-14% -$2.19M 0.02% 645
2013
Q2 		$15.6M Buy
+250,103
New +$15.9M 0.03% 517

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's GSK Position: Q4 2016 in Review

BlackRock Investment Management reduced its GSK (GSK) stake by 9.8% in Q4 2016, selling an estimated $1.92M and leaving 356,374 shares worth $17.2M. The position accounts for 0.02% of the portfolio, ranked #766.

BlackRock Investment Management first reported a position in GSK in Q2 2013 and has held it in 15 quarters since. The position peaked at $36.7M in Q2 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • BlackRock Investment Management held 356,374 shares of GSK worth $17.2M as of Q4 2016.
  • BlackRock Investment Management sold 38,840 GSK shares in Q4 2016, an estimated $1.92M.
  • GSK made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #766 holding.
  • BlackRock Investment Management first reported a position in GSK in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's GSK position peaked at $36.7M in Q2 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.